1. Home
  2. XYF vs OSUR Comparison

XYF vs OSUR Comparison

Compare XYF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XYF

X Financial each representing six

HOLD

Current Price

$4.06

Market Cap

224.3M

Sector

Finance

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$3.06

Market Cap

214.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XYF
OSUR
Founded
2014
2000
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.3M
214.1M
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
XYF
OSUR
Price
$4.06
$3.06
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
182.6K
495.4K
Earning Date
05-18-2026
05-06-2026
Dividend Yield
13.60%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$167,064,000.00
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
$7.76
P/E Ratio
$0.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.30
$2.08
52 Week High
$20.36
$3.76

Technical Indicators

Market Signals
Indicator
XYF
OSUR
Relative Strength Index (RSI) 40.41 53.35
Support Level N/A $3.05
Resistance Level $5.07 $3.38
Average True Range (ATR) 0.37 0.18
MACD -0.04 -0.01
Stochastic Oscillator 41.58 41.04

Price Performance

Historical Comparison
XYF
OSUR

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: